1290 VT SmartBeta Equity ESG Portfolio ABT Holdings History
1290 VT SmartBeta Equity ESG Portfolio's Abbott Laboratories Holding Summary
As of 2025-03-31, 1290 VT SmartBeta Equity ESG Portfolio held 24,994.00 shares of Abbott Laboratories(ABT), totaling $3.32 Mil. This investment constitutes 0.95% of their stock portfolio, and 1290 VT SmartBeta Equity ESG Portfolio now holds 0% of the outstanding Abbott Laboratories(ABT) stock.
The initial trade took place in 2019Q3. And since then 1290 VT SmartBeta Equity ESG Portfolio has made 4 purchases of ABT, at an average price of $106.77, for a total of 37,140.00 shares. In addition, there have been 2 sales at an average price of $112.92 for 12,146.00 shares. Based on historical transaction data and ABT's current price of $123.67, 1290 VT SmartBeta Equity ESG Portfolio's estimated gain on his ABT holdings is $497,139.43, reflecting a 12.54% gain to date.
1290 VT SmartBeta Equity ESG Portfolio ABT ($123.67) Holding Chart
1290 VT SmartBeta Equity ESG Portfolio ABT ($123.67) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1